Yongxi Zhang

601 Jinsui Road
Xinxiang, 453007, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Buspirone hydrochloride: a potential regulator of PD-L1 for enhanced antitumor activity in melanoma-bearing mice.

Buspirone hydrochloride: a potential regulator of PD-L1 for enhanced antitumor activity in melanoma-bearing mice.

Journal: Journal of drug targeting

Published: January 05, 2026

Venlafaxine suppressed PD-L1 expression through oxidative stress and improved anti-tumour immune responses in melanoma mice.

Venlafaxine suppressed PD-L1 expression through oxidative stress and improved anti-tumour immune responses in melanoma mice.

Journal: Journal of drug targeting

Published: December 23, 2025

Tumor-promoting effect and tumor immunity of SRSFs.

Tumor-promoting effect and tumor immunity of SRSFs.

Journal: Frontiers in cell and developmental biology

Published: November 13, 2024

MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype.

MDM2 inhibitor induces apoptosis in colon cancer cells through activation of the CHOP-DR5 pathway, independent of p53 phenotype.

Journal: Frontiers in pharmacology

Published: October 09, 2024

Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.

Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma.

Journal: eLife

Published: March 05, 2024

Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement.

Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement.

Journal: Cell death discovery

Published: May 05, 2023

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.

To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.

Journal: Frontiers in bioscience (Landmark edition)

Published: October 29, 2022

IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma Growth.

IDO2-siRNA Carried by Salmonella Combined with Nifuroxazide Attenuates Melanoma Growth.

Journal: Current molecular pharmacology

Published: July 21, 2022

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension.

LOX-1 Deletion Attenuates Myocardial Fibrosis in the Aged Mice, Particularly Those With Hypertension.

Journal: Frontiers in cardiovascular medicine

Published: July 04, 2021

Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.

Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.

Journal: Exploration of targeted anti-tumor therapy

Published: January 01, 2021

Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.

Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: July 21, 2020

Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.

Combination of attenuated Salmonella carrying PD-1 siRNA with nifuroxazide for colon cancer therapy.

Journal: Journal of cellular biochemistry

Published: April 09, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026